SMTL ID : 4zfo.2 (1 other biounit)

J22.9-xi: chimeric mouse/human antibody against human BCMA (CD269)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x CU: COPPER (II) ION(Non-covalent)

CU.1: 1 residues within 4Å: Chain A: D.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:D.1 CU.2: 2 residues within 4Å: Chain A: H.189 Ligands: BTB.3 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:H.189

1 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)

BTB.3: 4 residues within 4Å: Chain A: D.185, K.188, H.189 Ligands: CU.2 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.185 Salt bridges: A:D.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Oden, F. et al., Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma. Mol Oncol (2015)

Release Date

2015-05-20

Peptides

J22.9-xi Fab, Light Chain: A
J22.9-xi Fab, Heavy Chain: B
Tumor necrosis factor receptor superfamily member 17: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
K

J22.9-xi Fab, Light Chain

J22.9-xi Fab, Heavy Chain

Tumor necrosis factor receptor superfamily member 17

Related Entries With Identical Sequence